This evaluation should include assessment of body mass index (BMI) to confirm eligibility (BMI 30, or 27 with at least one weight-related comorbidity such as hypertension, dyslipidemia, type 2 diabetes, or obstructive sleep apnea), previous weight loss attempts, and realistic expectations for treatment outcomes
How is Mounjaro administered
Methodology: The study authors conducted an exhaustive search through Medline and the Cochrane Library for RCTs assessing the maintenance doses of subcutaneous tirzepatide at 5, 10, or 15 mg once-weekly, or subcutaneous semaglutide at 0.5, 1.0, or 2.0 mg once-weekly, spanning a minimum of 12 weeks
The body wants balance, above all else
No nonsense approach that will work if youre ready for the commitment and change."
Tirzepatide dose escalates every 4 weeks